Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Infectious Diseases Therapeutics Market Research Reports

Titlepublishedprice

Mumps - Pipeline Review, H1 2016

By Global Markets Direct
"...... action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the repo......"
24-Feb-2016$2000

Smallpox - Pipeline Review, H1 2016

By Global Markets Direct
"...... anism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally,......"
24-Feb-2016$2000

Sepsis - Pipeline Review, H1 2016

By Global Markets Direct
"...... of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the r......"
24-Feb-2016$2000

Global Dermatophytic Onychomycosis Market 2016-2020

By Technavio
"...... ytes, and Epidermophyton floccosum, infects the skin, hair, or nails. It is often perceived by people to be an active and contagious infection. Onychomycosis may persist or worsen if not treated. The fungi that cause onychomycosis exist in common sit......"
17-Feb-2016$2500

Staphylococcus aureus Infections - Pipeline Review, H2 2015

By Global Markets Direct
"...... ons, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also re......"
31-Dec-2015$2000

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Pipeline Review, H2 2015

By Global Markets Direct
"...... therapeutic development for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and mol......"
30-Dec-2015$2000

Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2015

By Global Markets Direct
"...... mparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players inv......"
23-Dec-2015$2000

Streptococcus Pneumoniae Infection - Pipeline Review, H2 2015

By Global Markets Direct
"...... Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It a......"
16-Dec-2015$2000

Enterococcus faecium Infections - Pipeline Review, H2 2015

By Global Markets Direct
"...... , complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also revie......"
16-Dec-2015$2000

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2015

By Global Markets Direct
"...... nfections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It a......"
16-Dec-2015$2000

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy